Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Kyntra Bio (KYNB) Return on Invested Capital (2016 - 2025)

Historic Return on Invested Capital for Kyntra Bio (KYNB) over the last 11 years, with Q3 2025 value amounting to 0.47%.

  • Kyntra Bio's Return on Invested Capital fell 5300.0% to 0.47% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.47%, marking a year-over-year decrease of 5300.0%. This contributed to the annual value of 1.05% for FY2024, which is 31400.0% down from last year.
  • As of Q3 2025, Kyntra Bio's Return on Invested Capital stood at 0.47%, which was down 5300.0% from 0.45% recorded in Q2 2025.
  • Kyntra Bio's 5-year Return on Invested Capital high stood at 8.95% for Q1 2023, and its period low was 24.28% during Q4 2022.
  • For the 5-year period, Kyntra Bio's Return on Invested Capital averaged around 0.56%, with its median value being 0.47% (2025).
  • Its Return on Invested Capital has fluctuated over the past 5 years, first crashed by -232700bps in 2022, then soared by 265100bps in 2023.
  • Quarter analysis of 5 years shows Kyntra Bio's Return on Invested Capital stood at 1.01% in 2021, then plummeted by -2313bps to 24.28% in 2022, then surged by 109bps to 2.23% in 2023, then plummeted by -66bps to 0.76% in 2024, then plummeted by -37bps to 0.47% in 2025.
  • Its Return on Invested Capital stands at 0.47% for Q3 2025, versus 0.45% for Q2 2025 and 0.63% for Q1 2025.